Recorded Chinese product: 甲硝唑氯化钠注射液甲硝唑氯化钠注射液
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 江西赣南海欣药业股份有限公司Chinese legal name: 江西赣南海欣药业股份有限公司
主要成分Active Ingredients
- 注射用水Water for Injection (注射用水)
药物知识说明
注射用水是一种在国家药监局注册认定的药品。该药品含有注射用水-4ef6f8fd等成分。
该药品关联的活性成分包括：注射用水。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：江西赣南海欣药业股份有限公司Chinese legal name: 江西赣南海欣药业股份有限公司。
您可以探索含有相同成分的其他药品：注射用水-4ef6f8fd成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 甲硝唑氯化钠注射液) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Manufacturers recorded for this product: 江西赣南海欣药业股份有限公司Chinese legal name: 江西赣南海欣药业股份有限公司.
Explore other medicines containing the same ingredient: products containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 甲硝唑氯化钠注射液Recorded Chinese product: 甲硝唑氯化钠注射液
- 剂型Dosage form: 注射剂Injection
- 规格Specification: 100ml:500mg100 mL:500 mg
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
生产企业Manufacturer
- 江西赣南海欣药业股份有限公司Chinese legal name: 江西赣南海欣药业股份有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H36021172
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H36021172
Manufacturer
Chinese legal name: 江西赣南海欣药业股份有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
Protect from light and keep tightly closed.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H36021172
生产企业
江西赣南海欣药业股份有限公司(国产)
适应症
本品主要用于厌氧茵感染的治疗。
用法用量
静脉滴注： 1.成人常用量厌氧菌感染，静脉给药首次按体重15mg/kg（70kg成人为1g），维持量按体重7.5mg/kg，每6～8小时静脉滴注一次。 2.小儿常用量厌氧菌感染的注射剂量同成人。 3.渗透压摩尔浓度应为260～340mOsmol/kg。
不良反应
15～30%病例出现不良反应，以消化道反应最为常见，包括恶心、呕吐、食欲不振、腹泻、腹部绞痛，一般不影响治疗；神经系统症状有头痛、眩晕，偶有感觉异常、肢体麻木、共济失调、多发性神经炎等，大剂量可致抽搐。少数病例发生荨麻疹、潮红、瘙痒、膀胱炎、排尿困难、黑尿、口中金属味及白细胞减少等，一般为可逆性，停药后自行恢复。
禁忌
有活动性中枢神经系统疾患和血液病者及对本品过敏的患者禁用。
注意事项
(1)对诊断的干扰：本品的代谢产物可使尿液呈深红色。
贮藏
遮光，密闭保存。
规格
100ml:500mg
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.